Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Terbutaline vs IV Nitroglycerine for ECV
NCT02115256Phase 3Terminated
- Start
- Jul 2014
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of nitroglycerin in breech presentation (2 arms). Primary endpoint: Successful Version of the Fetus Into the Vertex Position at 1 hour. Started Jul 2014; status: terminated.
02
Drugs
nitroglycerin
03
Conditions
breech presentation
Beyond the preview
Go deeper on NCT02115256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02115256.